Abstract

Introduction: Breast cancer is the most common site−specific cancer in women and is the leading cause of death from cancer for women aged 20 to 59 yrs. It accounts for 27% of all newly diagnosed cancers in females and is responsible for 16% of the cancer− related deaths in women.

So a study based on clinical staging, pathological staging, and hormone receptor status is essential in the appropriate management of breast cancer patients.

Material and Methods: 50 breast cancer patients who attended the department of general surgery, king George hospital, Andhra medical college, Visakhapatnam between august 2017 to June 2019.

Result

• The commonest stages of presentation were stage II and stage III in both clinical and pathological staging.
• Patients with large tumors have advanced lymph node status
• There is between good linear correlation clinical stage and pathological stage
• 50% of cases have presented without lymphnodes
• Triple−negative cases were more common in patients with the advanced clinical and pathological stage. O Testing for ER, PR, Her2neu receptor status is recommended in all patients with breast cancer to facilitate neoadjuvant and adjuvant therapy and for assessing prognosis.

Conclusion

• Breast cancer is the most common site−specific cancer in women
• Carcinoma breast is mainly a disease of fifth and sixth decades. However, there is a rising incidence in younger population o Carcinoma breast most commonly affected right breast than left breast in my study with upper and outer quadrant being most commonly involved
• Young patients have presented with advanced−stage disease

Keywords: Breast cancer, Breast lump, Infiltrating ductal carcinoma.